Jeanne Shaheen actually said...
Despite the efforts in the last year's legislation, the Inflation Reduction Act to cap out-of-pocket costs for insulin for Medicare, at $35 a person, we still see challenges with affordability for insulin.
Context
Shaheen highlights ongoing affordability issues for insulin despite legislative efforts.
04/16/2024